XML 36 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 9,161 $ 9,882
Short-term investments 371 288
Trade receivables, less allowances of $503 in 2023 and $500 in 2022 6,020 6,218
Inventories:    
Finished products 3,944 3,805
Work in process 805 680
Materials 1,924 1,688
Total inventories 6,673 6,173
Prepaid expenses and other receivables 2,152 2,663
Total Current Assets 24,377 25,224
Investments 776 766
Property and equipment, at cost 20,605 20,212
Less: accumulated depreciation and amortization 11,323 11,050
Net property and equipment 9,282 9,162
Intangible assets, net of amortization 10,006 10,454
Goodwill 22,927 22,799
Deferred income taxes and other assets 6,426 6,033
Total Assets 73,794 74,438
Current Liabilities:    
Trade accounts payable 4,167 4,607
Salaries, wages and commissions 1,098 1,556
Other accrued liabilities 5,758 5,845
Dividends payable 888 887
Income taxes payable 334 343
Current portion of long-term debt 2,285 2,251
Total Current Liabilities 14,530 15,489
Long-term debt 14,615 14,522
Post-employment obligations, deferred income taxes and other long-term liabilities 7,417 7,522
Commitments and Contingencies
Shareholders’ Investment:    
Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued 0 0
Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2023: 1,986,904,170; 2022: 1,986,519,278 24,488 24,709
Common shares held in treasury, at cost — Shares: 2023: 247,957,371; 2022: 248,724,257 (15,307) (15,229)
Earnings employed in the business 35,868 35,257
Accumulated other comprehensive income (loss) (8,039) (8,051)
Total Abbott Shareholders’ Investment 37,010 36,686
Noncontrolling Interests in Subsidiaries 222 219
Total Shareholders’ Investment 37,232 36,905
Total Liabilities and Shareholders' Investment $ 73,794 $ 74,438